László Homolya

Title: László Homolya: Innovator in Transport Protein Assays

Introduction

László Homolya is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of biochemistry, particularly in the study of transport proteins. His innovative work has led to the development of a unique method for assessing the activity of these proteins, which are crucial for various biological processes.

Latest Patents

László Homolya holds a patent for a "Simple quantitative fluorescent assay method for determining the activity of transport proteins of interest." This invention focuses on a straightforward quantitative fluorescent assay method specifically designed to evaluate the activity of multi-drug resistance associated proteins (MRPs). The method involves using a well-sealed culture of polarized cells that express the transport protein of interest. These cells are grown to confluency on a permeable support, creating distinct apical and basolateral compartments. By contacting the cells with a cell-permeable non-fluorescent derivative of a fluorescent compound, the fluorescence intensity detected from the opposite compartment after incubation indicates the activity of the transport protein. This invention also includes methods for determining inhibitors and activators of transport proteins and assessing their localization in polarized cells.

Career Highlights

László Homolya is associated with Solvo Biotechnology, a company that focuses on innovative solutions in the field of drug transport and pharmacology. His work at Solvo Biotechnology has allowed him to further explore the implications of transport proteins in drug resistance and therapeutic efficacy.

Collaborations

László has collaborated with Raymond Evers, contributing to advancements in the understanding of transport proteins and their role in cellular processes.

Conclusion

László Homolya's contributions to the field of transport protein assays highlight his innovative spirit and dedication to scientific advancement. His patent reflects a significant step forward in understanding the mechanisms of drug resistance, which is vital for developing effective therapies.